Monkey IL-8 Platinum ELISA

Also known as: Protein 3-10C, CXCL8, NAP-1, GCP-1

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS640/3*

Cat. No. Size
BMS640/3 96 tests
BMS640/3TEN 10 x 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Monkey IL-8 Platinum ELISA.

Click on image to view more information.

  • Data for Monkey IL-8 Platinum ELISA.
Description

Description: The monkey IL-8 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of monkey IL-8. The monkey IL-8 ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Interleukin-8 selectively stimulates the ability of neutrophils and T-lymphocytes to invade injured or inflamed tissue. IL-8 also known as CXCL8 that is purified from peripheral blood monocytes is a 10 kDa protein showing at least 4 variant forms (77, 72, 70, and 69 amino acids, respectively) which differ in the length of the N-terminal and readily form dimers in solution. Two cystin-bridges are essential for the biological activity of IL-8.
Exogenous stimuli like LPS, but also IL-1, TNF-alpha and TNF-beta induce the secretion of IL-8 in a variety of different cell types including monocytes, endothelial and epithelial cells, peripheral blood mononuclear cells, dermal fibroblasts, keratinocytes, neutrophils, hepatocytes, synovial cells, and T-lymphocytes.

The activities of IL-8 are not species-specific. Human IL-8 is also active in rodent and rabbit cells and differs from all other cytokines in its ability to specifically activate neutrophil granulocytes. This chemokine activates multiple intracellular signaling pathways downstream of two cell-surface, G protein-coupled receptors (CXCR1 and CXCR2). The property of IL-8 to stimulate movement of neutrophils across endothelial monolayers in vitro supports the concept of a central role for this molecule in the accumulation of neutrophils at inflammatory lesions in vivo.

Details
Reactivity Monkey
Sample Volume 50 uL
Suitable Sample Types cell culture supernatant, serum (baboon, cynomolgus)
Sensitivity 3.0 U/mL
Standard Curve Range 19.5 - 1,250 U/mL
Components Aluminium pouch(es) with a Microwell Plate coated with monoclonal antibody to monkey IL-8
Biotin-Conjugate anti-monkey IL-8 polyclonal antibody
Streptavidin-HRP
Monkey IL-8 Standard Concentrate, 125000 U/ml
Sample Diluent
Assay Buffer Concentrate 20x (PBS with 1% Tween 20 and 10% BSA)
Wash Buffer Concentrate 20x (PBS with 1% Tween 20)
Substrate Solution (tetramethyl-benzidine)
Stop Solution (1M Phosphoric acid)
Blue-Dye
Green-Dye
Red-Dye
Adhesive Films
Reported Applications ELISA
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
BMS2017HS* Human IL-17A High Sensitivity ELISA ELISA RUO
BMS206INST* Human sL-selectin Instant ELISA ELISA RUO
BMS237INST* Human IL-7 Instant ELISA ELISA RUO
BMS813FF* Human Chemokine 6plex FlowCytomix Multiplex Multiplex RUO
References

Citations: Baize,S.; Marianneau,P.; Loth,P.; Reynard,S.; Journeaux,A.; Chevallier,M.; Tordo,N.; Deubel,V.; Contamin,H.. Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J Virol. 2009;83:5890-5903. (Link)

References: Baldwin,E.T.; Weber,I.T.; St,Charles R.; Xuan,J.C.; Appella,E.; Yamada,M.; Matsushima,K.; Edwards,B.F.; Clore,G.M.; Gronenborn,A.M.; .. Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc.Natl.Acad.Sci.U.S.A 1991;88:502-506. (Link)

Gimbrone,M.A.,Jr.; Obin,M.S.; Brock,A.F.; Luis,E.A.; Hass,P.E.; Hebert,C.A.; Yip,Y.K.; Leung,D.W.; Lowe,D.G.; Kohr,W.J.; .. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 1989;246:1601-1603. (Link)

Van,Damme J.; Bunning,R.A.; Conings,R.; Graham,R.; Russell,G.; Opdenakker,G.. Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin 8. Cytokine 1990;2:106-111. (Link)

Smith,W.B.; Gamble,J.R.; Clark-Lewis,I.; Vadas,M.A.. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991;72:65-72. (Link)

Grob,P.M.; David,E.; Warren,T.C.; DeLeon,R.P.; Farina,P.R.; Homon,C.A.. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. J.Biol.Chem. 1990;265:8311-8316. (Link)

Martich,G.D.; Danner,R.L.; Ceska,M.; Suffredini,A.F.. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J.Exp.Med. 1991;173:1021-1024. (Link)

Larsen,C.G.; Anderson,A.O.; Oppenheim,J.J.; Matsushima,K.. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 1989;68:31-36. (Link)

Seitz,M.; Dewald,B.; Gerber,N.; Baggiolini,M.. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J.Clin.Invest 1991;87:463-469. (Link)

Detmers,P.A.; Lo,S.K.; Olsen-Egbert,E.; Walz,A.; Baggiolini,M.; Cohn,Z.A.. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J.Exp.Med. 1990;171:1155-1162. (Link)

Kunkel,S.L.; Standiford,T.; Kasahara,K.; Strieter,R.M.. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp.Lung Res. 1991;17:17-23. (Link)

Baggiolini,M.; Walz,A.; Kunkel,S.L.. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J.Clin.Invest 1989;84:1045-1049. (Link)

Peichl,P.; Ceska,M.; Effenberger,F.; Haberhauer,G.; Broell,H.; Lindley,I.J.. Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand.J.Immunol. 1991;34:333-339. (Link)

Sticherling,M.; Bornscheuer,E.; Schroder,J.M.; Christophers,E.. Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J.Invest Dermatol. 1991;96:26-30. (Link)

Lindley,I.; Aschauer,H.; Seifert,J.M.; Lam,C.; Brunowsky,W.; Kownatzki,E.; Thelen,M.; Peveri,P.; Dewald,B.; von,Tscharner,V; .. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc.Natl.Acad.Sci.U.S.A 1988;85:9199-9203. (Link)

Puchner,T.; Egarter,C.; Wimmer,C.; Lederhilger,F.; Weichselbraun,I.. Amniotic fluid interleukin-8 as a marker for intraamniotic infection. Arch.Gynecol.Obstet. 1993;253:9-14. (Link)

DeMarco,D.; Kunkel,S.L.; Strieter,R.M.; Basha,M.; Zurier,R.B.. Interleukin-1 induced gene expression of neutrophil activating protein (interleukin-8) and monocyte chemotactic peptide in human synovial cells. Biochem.Biophys.Res.Commun. 1991;174:411-416. (Link)

Matsushima,K.; Oppenheim,J.J.. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1989;1:2-13. (Link)

Peichl,P.; Ceska,M.; Broell,H.; Effenberger,F.; Lindley,I.J.. Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Ann.Rheum.Dis. 1992;51:19-22. (Link)

Elford,P.R.; Cooper,P.H.. Induction of neutrophil-mediated cartilage degradation by interleukin-8. Arthritis Rheum. 1991;34:325-332. (Link)

Tilg,H.; Ceska,M.; Vogel,W.; Herold,M.; Margreiter,R.; Huber,C.. Interleukin-8 serum concentrations after liver transplantation. Transplantation 1992;53:800-803. (Link)